<DOC>
	<DOC>NCT02843906</DOC>
	<brief_summary>The purpose of this study is to identify association between cerebrospinal fluid Alzheimer's Disease's neurodegenerescence biomarkers (tau, ptau, Aß40 and Aß1-42) and occurrence of cognitive deficits in older patients with bipolar disorders.</brief_summary>
	<brief_title>Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Plaque, Amyloid</mesh_term>
	<criteria>male or female subject aged between 60 and 80 years old in patient or outpatient at one of the centers participating in the study Minimental state examination (MMSE) score &gt; 20 at baseline patient with diagnostic of amnesticMild Cognitive Impairment patients suffering of bipolar disorders type I or II in remitted (euthymic) state at baseline preexisting history of dementia history of neurologic disorder lifetime history of a severe psychiatric disorder other than bipolar disorders current medical problems patients treated with electroconvulsive therapy within the past six months patients with substance abuse or dependence within the past 12 months patients hospitalized without consent</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>alzheimer disease</keyword>
	<keyword>bipolar disorders</keyword>
	<keyword>mild cognitive impairement</keyword>
</DOC>